Last reviewed · How we verify
NCT05329142: ASSIST
ASSIST: A Surveillance Study of Illicit Substance Toxicity
trial testing Surplus sample toxicology analysis in Overdose, Drug in 1,000 participants. Status unknown.
19 August 2023
Quick facts
| Lead sponsor | NHS Greater Glasgow and Clyde |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 19 August 2022 |
| Primary completion | 19 August 2023 |
| Estimated completion | 19 August 2023 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Surplus sample toxicology analysis
Conditions studied
- Overdose, Drug — all drugs for Overdose, Drug →
- Drug Use — all drugs for Drug Use →
- Drug Abuse — all drugs for Drug Abuse →
- Drug Toxicity — all drugs for Drug Toxicity →
Sponsor
NHS Greater Glasgow and Clyde — full company profile →
Who can join
16 and older, any sex, with Overdose, Drug or Drug Use. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
There is a drug-related death crisis in Scotland. This study aims to collaborate with Public Health Scotland in order to assess the feasibility of introducing a surveillance system to the Emergency Department to highlight illicit drug-related attendances. This will utilise both clinical data and toxiclogical analysis of anonymised samples. The data will inform of prevalence, trend data and utcome of ED patients attending with acute illict drug toxicity.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Clinical characterisation of the novel benzodiazepine bromazolam-data from the ASSIST (A Surveillance Study of Illicit Substance Toxicity) study.
Dunlop LC, Craik V, Jarvie N, Hudson S, et al · · 2025 · PMID 40719187 · DOI 10.1080/15563650.2025.2524078
Verify or expand the search:
- PubMed search for NCT05329142
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other NHS Greater Glasgow and Clyde trials
Trials by the same sponsor.
- NCT07403890 — Rewiring the Brain-Immune Axis for Chronic Pain Using Transcranial Magnetic Stimulation in Psoriatic Arthritis · NA · not yet recruiting
- NCT07372508 — Glasgow Low-dose CT and AI-based Diagnostics to Case Find Lung Cancer and Other Cardio-respiratory Long-term Conditions · NA · not yet recruiting
- NCT07391280 — Strategy for EArly Recognition of Cancer, COPD & Heart Failure in the Emergency Department · NA · not yet recruiting
- NCT07048184 — Sarcoma Surgery Wound Complications Comparing Usual Versus Negative Pressure Dressing · Phase 2 · not yet recruiting
- NCT06786936 — Evaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05329142 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NHS Greater Glasgow and Clyde
- Last refreshed: 19 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05329142.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing